Roth Capital Forecasts OTC:GTBIF FY2024 Earnings

Green Thumb Industries Inc. (OTC:GTBIF) – Investment analysts at Roth Capital issued their FY2024 earnings per share (EPS) estimates for Green Thumb Industries in a note issued to investors on Sunday, November 10th. Roth Capital analyst W. Kirk expects that the company will post earnings per share of $0.32 for the year. Roth Capital currently has a “Strong-Buy” rating on the stock. The consensus estimate for Green Thumb Industries’ current full-year earnings is $0.33 per share. Roth Capital also issued estimates for Green Thumb Industries’ Q4 2024 earnings at $0.07 EPS, Q1 2025 earnings at $0.07 EPS, Q2 2025 earnings at $0.08 EPS, Q3 2025 earnings at $0.07 EPS, Q4 2025 earnings at $0.08 EPS and FY2025 earnings at $0.30 EPS.

A number of other research analysts also recently issued reports on the company. Ventum Cap Mkts raised Green Thumb Industries to a “strong-buy” rating in a research note on Tuesday, August 6th. Craig Hallum raised Green Thumb Industries to a “strong-buy” rating in a research note on Monday, September 16th.

Green Thumb Industries Trading Up 14.7 %

Shares of GTBIF stock opened at $8.95 on Wednesday. Green Thumb Industries has a 1-year low of $7.50 and a 1-year high of $16.33. The firm has a market capitalization of $1.89 billion, a PE ratio of 33.15 and a beta of 1.40. The company has a 50-day moving average of $10.24.

Green Thumb Industries Company Profile

Green Thumb Industries Inc manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States. It operates through two segments, Retail and Consumer Packaged Goods. The company offers cannabis flower; processed and packaged products, including pre-rolls, concentrates, vapes, capsules, tinctures, edibles, topicals, and other cannabis-related products under the &Shine, Beboe, Dogwalkers, Doctor Solomon’s, Good Green, incredibles, and RHYTHM brands.